Comments and Response on the USPSTF Recommendation on Screening for Breast Cancer

Victoria L. Seewaldt

doi:10.7326/0003-4819-152-8-201004200-00205

Comments and Response on the USPSTF Recommendation on Screening for Breast Cancer Free

Victoria L. Seewaldt, MD

Article, Author, and Disclosure Information

TO THE EDITOR:

The USPSTF (1) recently recommended against routine mammography screening in women aged 40 to 49 years. The recommendation was based on the relative probability of unscreened women dying of breast cancer and the reduction in mortality provided by mammographic screening. On the basis of these studies, the USPSTF issued a blanket recommendation against routine screening mammography in all women aged 40 to 49 years.

The USPSTF study lacks evidence to support a reduction in mammography screening in African-American and Latino women who are younger than 50 years (1). The USPSTF study analyzed the risk–benefit ratio of mammography as a function of a woman's age but did not consider the potential contributions of race and ethnicity (1). Investigators did not state the racial and ethnic composition of study participants and did not analyze the risk–benefit ratio of mammography in African-American and Latino women (1). It is concerning that the USPSTF issued a one-size-fits-all recommendation on breast cancer screening without considering whether the recommendation is appropriate for all women.

Our current recommendations for mammography screening are based on studies in European, European-Canadian, and European-American women. Eight randomized trials (2) studied the effectiveness of mammography in the United States, Sweden, Canada, and the United Kingdom. These studies balance the relative contributions of mammographic density (sensitivity and specificity of mammography) and the mortality rate from breast cancer (2). To our knowledge, there has been no large-scale analysis of the effectiveness of mammographic screening in African-American and Latino women.

Studies of mammography screening in women aged 40 to 49 years are complex because younger women have a lower incidence of breast cancer; denser breast tissue (which can lower sensitivity); and on average, faster growing, biologically aggressive cancer. Relative to European-American women, African-American women have lower breast density, faster-growing cancer, and a higher likelihood of dying to breast cancer (3–5). Because the mortality rate from breast cancer in African-American women is higher and mammographic density is typically lower, the benefit from mammography screening is probably higher in African-American and perhaps Latino women than in European-American women. So where is the evidence to recommend against routine mammography screening of African-American and Latino women younger than 50 years?

We agree with the USPSTF that change is needed. But the change we call for is the end of one-size-fits-all recommendations and the inclusion of African-American and Latino women in clinical trials testing the benefit of mammographic screening.

Victoria L. Seewaldt, MD

Duke University

Durham, NC 27708

References

U.S. Preventive Services Task Force
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med
2009
151
PubMed
Elmore
JG
Armstrong
K
Lehman
CD
Fletcher
SW
Screening for breast cancer.
JAMA
2005
293
1245
56
PubMed
CrossRef
Stuedal
A
Ma
H
Bernstein
L
Pike
MC
Ursin
G
Does breast size modify the association between mammographic density and breast cancer risk?
Cancer Epidemiol Biomarkers Prev
2008
17
621
7
PubMed
Ursin
G
Ma
H
Wu
AH
Bernstein
L
Salane
M
Parisky
YR
et al.
Mammographic density and breast cancer in three ethnic groups.
Cancer Epidemiol Biomarkers Prev
2003
12
332
8
PubMed
Elledge
RM
Clark
GM
Chamness
GC
Osborne
CK
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
J Natl Cancer Inst
1994
86
705
12
PubMed

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More

Letters |20 April 2010

Comments and Response on the USPSTF Recommendation on Screening for Breast Cancer Free

References

Clinical Slide Sets

This feature is available only to Registered Users

0 Comments

See Also

Content

Information For

Services

Awards

Other Resources

Follow Annals On

Letters |20 April 2010

Comments and Response on the USPSTF Recommendation on Screening for Breast Cancer Free

References

Clinical Slide Sets

This feature is available only to Registered Users

0 Comments

See Also

Content

Information For

Services

Awards

Other Resources

Follow Annals On

You need a subscription to this content to use this feature.